SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 215 filers reported holding SANGAMO THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 1.04 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $447,588 | +255.5% | 745,980 | +670.3% | 0.00% | – |
| Q2 2023 | $125,902 | -73.3% | 96,847 | -63.8% | 0.00% | – |
| Q1 2023 | $470,999 | -74.7% | 267,613 | -54.8% | 0.00% | -100.0% |
| Q4 2022 | $1,859,050 | +257.5% | 592,054 | +457.1% | 0.00% | – |
| Q3 2022 | $520,000 | -36.4% | 106,269 | -46.2% | 0.00% | – |
| Q2 2022 | $818,000 | -69.4% | 197,616 | -57.1% | 0.00% | -100.0% |
| Q1 2022 | $2,675,000 | -12.7% | 460,380 | +12.7% | 0.00% | 0.0% |
| Q4 2021 | $3,063,000 | +17.3% | 408,412 | +40.9% | 0.00% | 0.0% |
| Q3 2021 | $2,612,000 | +89.3% | 289,855 | +151.4% | 0.00% | – |
| Q2 2021 | $1,380,000 | -68.1% | 115,284 | -66.7% | 0.00% | -100.0% |
| Q1 2021 | $4,332,000 | +613.7% | 345,728 | +789.1% | 0.00% | – |
| Q4 2020 | $607,000 | +427.8% | 38,887 | +219.7% | 0.00% | – |
| Q3 2020 | $115,000 | -91.4% | 12,162 | -91.9% | 0.00% | -100.0% |
| Q2 2020 | $1,345,000 | +790.7% | 150,096 | +530.9% | 0.00% | – |
| Q1 2020 | $151,000 | +2.7% | 23,792 | +36.1% | 0.00% | – |
| Q4 2019 | $147,000 | -90.8% | 17,475 | -90.1% | 0.00% | -100.0% |
| Q3 2019 | $1,590,000 | +49.4% | 175,717 | +77.8% | 0.00% | – |
| Q2 2019 | $1,064,000 | +466.0% | 98,805 | +400.3% | 0.00% | – |
| Q1 2019 | $188,000 | -95.0% | 19,749 | -94.0% | 0.00% | -100.0% |
| Q4 2018 | $3,767,000 | +96.2% | 328,159 | +189.8% | 0.00% | +100.0% |
| Q3 2018 | $1,920,000 | +76.6% | 113,253 | +47.9% | 0.00% | – |
| Q2 2018 | $1,087,000 | -72.6% | 76,563 | -63.3% | 0.00% | -100.0% |
| Q1 2018 | $3,966,000 | +2153.4% | 208,744 | +1846.0% | 0.00% | – |
| Q4 2017 | $176,000 | -12.0% | 10,727 | -19.3% | 0.00% | – |
| Q3 2017 | $200,000 | -25.7% | 13,294 | -56.5% | 0.00% | – |
| Q2 2017 | $269,000 | +647.2% | 30,558 | +346.1% | 0.00% | – |
| Q1 2017 | $36,000 | -35.7% | 6,850 | -62.7% | 0.00% | – |
| Q4 2016 | $56,000 | -32.5% | 18,381 | +1.9% | 0.00% | – |
| Q3 2016 | $83,000 | -58.1% | 18,044 | -47.3% | 0.00% | – |
| Q2 2016 | $198,000 | +144.4% | 34,224 | +153.5% | 0.00% | – |
| Q1 2016 | $81,000 | -41.3% | 13,500 | -11.1% | 0.00% | – |
| Q4 2015 | $138,000 | +68.3% | 15,193 | +4.8% | 0.00% | – |
| Q3 2015 | $82,000 | -59.6% | 14,500 | -20.8% | 0.00% | – |
| Q2 2015 | $203,000 | -51.8% | 18,300 | -31.8% | 0.00% | – |
| Q1 2015 | $421,000 | -59.1% | 26,817 | -60.4% | 0.00% | – |
| Q4 2014 | $1,029,000 | – | 67,686 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Golden State Equity Partners | 154,360 | $897,000 | 0.45% |
| Rhenman & Partners Asset Management AB | 761,429 | $4,424,000 | 0.44% |
| Lombard Odier Asset Management (Switzerland) SA | 860,702 | $5,001,000 | 0.39% |
| WASATCH ADVISORS LP | 10,576,997 | $61,452,000 | 0.30% |
| Rokos Capital Management LLP | 977,663 | $5,861,000 | 0.27% |
| KLK CAPITAL MANAGEMENT LLC | 44,323 | $258,000 | 0.26% |
| Long Focus Capital Management, LLC | 340,000 | $1,975,000 | 0.25% |
| Vanguard Capital Wealth Advisors | 33,380 | $193,000 | 0.14% |
| Fort Sheridan Advisors LLC | 73,978 | $430,000 | 0.13% |
| Delphia (USA) Inc. | 20,983 | $122,000 | 0.09% |